Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in Jordan
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationOpen-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
- Where
- Amman
- People
- 175 worldwide
- Run by
- Wave Life Sciences USA, Inc.
See details and how to joinNCT07209332